急性心肌梗塞静脉溶栓治疗的观察及护理干预

急性心肌梗塞静脉溶栓治疗是通过静脉给药的途径，使溶栓药物在血液中迅速达到高峰，以达到溶解冠状动脉内的血栓，减少心肌梗死的范围，改善心脏功能。首选的药物是重组链激酶（R—SK）。我科通过严格的筛选病例，选出9例病人进行重组链激酶溶栓治疗。取得了较好的临床效果。

Intravenous thrombolysic treatment in acute myocardia infarction, means to make a rapid peak concentration of thrombolysic drug in blood, as a result, the thrombi in coronary arteries are melted and consequently the area of infarction could be reduced, namely a improved cardiac function. RSK is a preferred drug for this therapy. Our department treated 9 strictly selected patients with RSK thrombolysic therapy; all cases showed acceptable clinical effects.